store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Clavulanic Acid(RX-10100) 是一种由生物体克拉维链霉菌产生的主要β-内酰胺类抗生素,是一种强效的细菌 β-内酰胺酶抑制剂,用于研究细菌引起的感染。Clavulanic Acid 具有广谱的生物活性,对多种革兰氏阳性和革兰氏阴性细菌均有活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 165 | 现货 | ||
5 mg | ¥ 257 | 现货 | ||
10 mg | ¥ 413 | 现货 | ||
25 mg | ¥ 578 | 现货 | ||
50 mg | ¥ 747 | 现货 |
产品描述 | Clavulanic Acid(RX-10100), a major beta-lactam antibiotic produced by the organism Streptomyces claveris, is a potent bacterial beta-lactamase inhibitor used in the study of infections caused by bacteria. Clavulanic Acid has a broad spectrum of biological activity and is active against a wide variety of Gram-positive and Gram-negative bacteria. |
体外活性 |
Clavulanic acid exhibits synergistic antibacterial activity with ampicillin against microorganisms producing β-lactamase[2]. Clavulanic acid inhibits strains Ab11 and Ab51 with a minimum inhibitory concentration (MIC) ranging from 2 to 8 μg/mL[4]. |
体内活性 |
In C57BL/6 mice with Pseudomonas aeruginosa pneumonia, intraperitoneal injection of clavulanic acid (13 mg/kg) reduces bacterial burden in the lungs[4]. In C57BL/6 mice infected with Ab51, intraperitoneal injection of clavulanic acid (13 mg/kg) shows a half-life (t1/2) of 6.69 hours and an area under the curve (AUC) of 4.03 mg·h/L in a lung infection model[4]. In a rat model of carrageenan-induced paw edema, intraperitoneal injection of clavulanic acid (100-300 mg/kg) exhibits anti-inflammatory effects[3]. |
别名 | BRL 14151, MM-14151, MM 14151, RX-10100, MM14151, BRL14151, BRL-14151 |
分子量 | 199.16 |
分子式 | C8H9NO5 |
CAS No. | 58001-44-8 |
store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (50.21 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 5.0211 mL | 25.1054 mL | 50.2109 mL | 125.5272 mL |
5 mM | 1.0042 mL | 5.0211 mL | 10.0422 mL | 25.1054 mL | |
10 mM | 0.5021 mL | 2.5105 mL | 5.0211 mL | 12.5527 mL | |
20 mM | 0.2511 mL | 1.2553 mL | 2.5105 mL | 6.2764 mL | |
50 mM | 0.1004 mL | 0.5021 mL | 1.0042 mL | 2.5105 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Clavulanic Acid 58001-44-8 Microbiology/Virology Antifungal Antibacterial BRL 14151 MM-14151 MM 14151 RX-10100 MM14151 BRL14151 BRL-14151 Inhibitor inhibitor inhibit